PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

In 51C's January update a value of $10bn was mentioned for...

  1. 593 Posts.
    lightbulb Created with Sketch. 135
    In 51C's January update a value of $10bn was mentioned for solely MPS. This was based on $1bn of revenue and a similar multiple to Biomarin's revenue (10x).

    $10bn equates to over $40 per share. Still a long way to go but hope they are in the ballpark.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
23.5¢
Change
0.005(2.17%)
Mkt cap ! $82.20M
Open High Low Value Volume
23.5¢ 23.5¢ 23.0¢ $85.35K 365.1K

Buyers (Bids)

No. Vol. Price($)
10 280011 23.0¢
 

Sellers (Offers)

Price($) Vol. No.
24.0¢ 44703 3
View Market Depth
Last trade - 16.10pm 06/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.